-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Elevance Health, Raises Price Target to $408

Benzinga·04/24/2026 18:18:50
Listen to the news
Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $393 to $408.